Literature DB >> 17646752

A novel mutation in the VMD2 gene in an Italian family with Best maculopathy.

A Sodi1, I Passerini, F Simonelli, F Testa, U Menchini, F Torricelli.   

Abstract

Vitelliform macular dystrophy (Best disease) is an inherited macular degeneration in which the primary defect is thought to occur at the level of the retinal pigment epithelium. The VMD2 gene, considered responsible for the disease, mapped to the long arm of chromosome 11, and it codifies the bestrophin protein, probably acting as a transmembrane ionic channel. In the present study, we screened for mutations the VMD2 gene in Italian patients with Best maculopathy. Five families with Best disease were recruited from central and southern Italy, and family members were evaluated by complete ophthalmologic examination and DNA analysis by means of DHPLC technology. Some mutations of the VMD2 gene were identified and among them there was a novel mutation (R218G), probably involving a functionally active region of the bestrophin protein. In spite of the small number of families considered, it was possible to note a significant phenotypic heterogeneity. First, in one family the R218C mutation was associated with early onset of choroidal neovascularization (CNV) in the affected mother and her son, while no CNV was reported in another family sharing the same mutation. Then a patient with the R25W mutation showed a multifocal location of the vitelliform deposits, while another family with the same mutation showed a typical isolated vitelliform disc in the macular area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646752     DOI: 10.1016/s0181-5512(07)89667-7

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  5 in total

1.  Phenotypic variability due to a novel Glu292Lys variation in exon 8 of the BEST1 gene causing best macular dystrophy.

Authors:  Elliott H Sohn; Peter J Francis; Jacque L Duncan; Richard G Weleber; David A Saperstein; Donald F Farrell; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2009-07

Review 2.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

3.  Two novel mutations in the bestrophin-1 gene and associated clinical observations in patients with best vitelliform macular dystrophy.

Authors:  Ying Lin; Hongbin Gao; Yuhua Liu; Xuanwei Liang; Xialin Liu; Zhonghao Wang; Wanjun Zhang; Jiangna Chen; Zhuoling Lin; Xinhua Huang; Yizhi Liu
Journal:  Mol Med Rep       Date:  2015-04-30       Impact factor: 2.952

4.  Clinical and Mutation Analysis of Patients with Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy in Chinese Population.

Authors:  Tingting Gao; Chengqiang Tian; Qinrui Hu; Zhiming Liu; Jimei Zou; Lvzhen Huang; Mingwei Zhao
Journal:  Biomed Res Int       Date:  2018-10-18       Impact factor: 3.411

5.  BEST1 sequence variants in Italian patients with vitelliform macular dystrophy.

Authors:  Andrea Sodi; Ilaria Passerini; Vittoria Murro; Roberto Caputo; Giacomo Maria Bacci; Mirela Bodoj; Francesca Torricelli; Ugo Menchini
Journal:  Mol Vis       Date:  2012-11-17       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.